Federal contract award

HT942523C0019

DHA SBIR PHASE II - TOPIC DHA213-004 PROPOSAL H2-0724, CONTRACTOR OLIFANT MEDICAL INC., TITLED BOUGIE INTEGRATED ENDOTRACHEAL INTUBATION STYLET, MEDICAL R & D, EGS LOG 2200472

Research the contractorView USAspending sourceSave to my pursuit research

Award details

Obligations, current value and potential value describe different measures; they are never added together.

FieldReported value
AgencyDepartment of Defense
OfficeARMY MED RES ACQ ACTIVITY
NAICS541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
PSCAN11 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH
Parent award / vehicleNot reported
Set-asideSMALL BUSINESS SET ASIDE - TOTAL
Pricing typeFIRM FIXED PRICE
Obligations$1.1M
Current contract value$1.1M
Potential contract value / ceiling$1.1M
Start dateMar 8, 2023
Current end dateJul 7, 2025
Potential end dateJul 7, 2025
Latest award activityApr 13, 2023
Source loadedSep 26, 2026

Funding and modification history

Showing the latest 2 of 2 loaded transactions. Negative values are deobligations.

DateModificationObligation changeDescription
Apr 13, 2023P00001$0DHA SBIR PHASE II - TOPIC DHA213-004 PROPOSAL H2-0724, CONTRACTOR OLIFANT MEDICAL INC., TITLED BOUGIE INTEGRATED ENDOTRACHEAL INTUBATION STYLET, MEDICAL R & D, EGS LOG 2200472
Mar 1, 20230$1.1MDHA SBIR PHASE II - TOPIC DHA213-004 PROPOSAL H2-0724, CONTRACTOR OLIFANT MEDICAL INC., TITLED BOUGIE INTEGRATED ENDOTRACHEAL INTUBATION STYLET, MEDICAL R & D, EGS LOG 2200472

Research next steps

  1. Check the stated set-aside against the solicitation and current certifications.
  2. Review the award scope and buyer evidence before making a bid/no-bid decision.